More importantly, orlistat effectively attenuated tumor weight by inhibiting FAS and inducing apoptosis in all three diet intervention mouse groups (HFD, LFD, HFD-LFD), and decreased angiogenesis by reducing the expression of MMP-9 and VEGF of EC tumors in HFD and HFD-LFD mice. Here, FAS is linked to neoplasm.